WallStreetZenWallStreetZen

NASDAQ: IINN
Inspira Technologies Oxy Bhn Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IINN

Based on 1 analyst offering 12 month price targets for Inspira Technologies Oxy Bhn Ltd

Min Forecast
$2.00+175.48%
Avg Forecast
$2.00+175.48%
Max Forecast
$2.00+175.48%

Should I buy or sell IINN stock?

Based on 1 analyst offering ratings for Inspira Technologies Oxy Bhn Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IINN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IINN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their IINN stock forecasts and price targets.

IINN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-02

1 of 1

Forecast return on equity

Is IINN forecast to generate an efficient return?

Company
-202.01%
Industry
19.67%
Market
56.76%
IINN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IINN forecast to generate an efficient return on assets?

Company
-108.19%
Industry
10.5%
IINN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IINN earnings per share forecast

What is IINN's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.38
Avg 2 year Forecast
-$0.36

IINN revenue forecast

What is IINN's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.0M
Avg 2 year Forecast
$300.0M

IINN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
IINN$0.73$2.00+175.48%Strong Buy
ADGM$1.09N/AN/A
ALUR$2.48$9.25+272.98%Buy
IRIX$0.94N/AN/A
XAIR$0.18N/AN/A
View Top Medical Device Stocks

Inspira Technologies Oxy Bhn Stock Forecast FAQ

Is Inspira Technologies Oxy Bhn Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IINN) stock is to Strong Buy IINN stock.

Out of 1 analyst, 1 (100%) are recommending IINN as a Strong Buy, 0 (0%) are recommending IINN as a Buy, 0 (0%) are recommending IINN as a Hold, 0 (0%) are recommending IINN as a Sell, and 0 (0%) are recommending IINN as a Strong Sell.

If you're new to stock investing, here's how to buy Inspira Technologies Oxy Bhn stock.

What is IINN's earnings growth forecast for 2025-2026?

(NASDAQ: IINN) Inspira Technologies Oxy Bhn's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Inspira Technologies Oxy Bhn's earnings in 2025 is -$11,053,000.On average, 1 Wall Street analyst forecast IINN's earnings for 2025 to be -$9,215,796, with the lowest IINN earnings forecast at -$9,215,796, and the highest IINN earnings forecast at -$9,215,796.

In 2026, IINN is forecast to generate -$8,730,755 in earnings, with the lowest earnings forecast at -$8,730,755 and the highest earnings forecast at -$8,730,755.

What is IINN's revenue growth forecast for 2025-2026?

(NASDAQ: IINN) Inspira Technologies Oxy Bhn's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Inspira Technologies Oxy Bhn's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast IINN's revenue for 2025 to be $2,425,209,600, with the lowest IINN revenue forecast at $2,425,209,600, and the highest IINN revenue forecast at $2,425,209,600.

In 2026, IINN is forecast to generate $7,275,628,800 in revenue, with the lowest revenue forecast at $7,275,628,800 and the highest revenue forecast at $7,275,628,800.

What is IINN's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: IINN) forecast ROA is -108.19%, which is lower than the forecast US Medical Devices industry average of 10.5%.

What is IINN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IINN price target, the average IINN price target is $2.00, with the highest IINN stock price forecast at $2.00 and the lowest IINN stock price forecast at $2.00.

The Wall Street analyst predicted that Inspira Technologies Oxy Bhn's share price could reach $2.00 by Jun 2, 2026. The average Inspira Technologies Oxy Bhn stock price prediction forecasts a potential upside of 175.48% from the current IINN share price of $0.73.

What is IINN's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: IINN) Inspira Technologies Oxy Bhn's current Earnings Per Share (EPS) is -$0.60. On average, analysts forecast that IINN's EPS will be -$0.38 for 2025, with the lowest EPS forecast at -$0.38, and the highest EPS forecast at -$0.38. In 2026, IINN's EPS is forecast to hit -$0.36 (min: -$0.36, max: -$0.36).

What is IINN's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: IINN) forecast ROE is -202.01%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.